Pharma 101 - Pharmaceutical Fraud » Indictment http://pharmaceutical-kickbacks.com Information & Insight On Qui Tam Lawsuits Based Upon Unlawful Kickbacks, Marketing & Pricing Conduct. Fri, 16 Dec 2011 21:42:34 +0000 en hourly 1 http://wordpress.org/?v=3.2 InterMune Pays Nearly $37 Million to Settle Claims for Off Label Marketing http://pharmaceutical-kickbacks.com/intermune-pays-nearly-37-million-to-settle-claims-for-off-label-marketing/ http://pharmaceutical-kickbacks.com/intermune-pays-nearly-37-million-to-settle-claims-for-off-label-marketing/#comments Mon, 30 Oct 2006 15:10:10 +0000 Nolan and Auerbach http://pharmaceutical-kickbacks.com/?p=132 InterMune Inc., a Brisbane, California, biopharmaceutical company, has agreed to pay the government $36.9 million to resolve criminal charges and civil liabilities in connection with allegations of illegally promoting Actimmune for treatment of idiopathic pulmonary fibrosis (IPF) or lung scarring despite not receiving approval for such treatment by the U.S. Food and Drug Administration. This settlement resolves allegations that InterMune caused the submission of false claims for Actimmune that were not eligible for reimbursement because they were for unnecessary or off label uses. The FDA had approved Actimmune for treating immune system disorders.

For more information please click here.

]]> http://pharmaceutical-kickbacks.com/intermune-pays-nearly-37-million-to-settle-claims-for-off-label-marketing/feed/ 0